Your search returned 2 results.

Results
	1.	Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. MedStar authors: Aroda, Vanita R PMID: 33468520 Year: 2021 Citation: Diabetes Care. 44(3):774-780, 2021 03. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Birkenfeld AL, Blonde L, Del Prato S, Frias J, Ji C, Niemoeller E, Rosenstock J, Souhami E DOI: https://dx.doi.org/10.2337/dc20-2023 Add to cart (remove)
	2.	Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. MedStar authors: Weintraub, William S PMID: 31023428 Year: 2019 Citation: Journal of the American College of Cardiology. 73(16):2049-2058, 2019 04 30. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Berman DS, Boden WE, COURAGE Trial Research Group, Hartigan PM, Kostuk WJ, Mancini GBJ, Maron DJ, Spertus JA, Teo KK, Weintraub WS DOI: https://dx.doi.org/10.1016/j.jacc.2018.11.067 Add to cart (remove)

Refine your search